Prostate Cancer Metastatic
Showing 1 - 25 of 90
Prospective Androgen Receptor Signaling Inhibitors Resistance
Not yet recruiting
- Prostate Cancer
- +3 more
- (no location specified)
Nov 15, 2023
Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)
Recruiting
- Prostate Cancer
- Prostate Cancer Metastatic
-
La Jolla, California
- +1 more
Feb 2, 2023
Prostate Cancer Metastatic Trial in New York, Knoxville (HB-302/HB-301 Alternating 2-Vector Therapy)
Recruiting
- Prostate Cancer Metastatic
- HB-302/HB-301 Alternating 2-Vector Therapy
-
New York, New York
- +1 more
Feb 1, 2023
Prostate Cancer Metastatic Trial in United States (ARV-766)
Recruiting
- Prostate Cancer Metastatic
- ARV-766 Part A
- ARV-766 Part B
-
Duarte, California
- +20 more
Jan 31, 2023
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed
Recruiting
- Prostate Cancer
- +4 more
- Darolutamide
- metastasis-directed treatment
-
Aalst, Belgium
- +6 more
Jan 25, 2023
Prostate Cancer Metastatic, Neuroendocrine Tumors Trial in Atlanta, Ann Arbor (Pembrolizumab, Lenvatinib)
Recruiting
- Prostate Cancer Metastatic
- Neuroendocrine Tumors
-
Duarte, California
- +2 more
Jan 18, 2023
Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)
Not yet recruiting
- Prostate Cancer
- +2 more
- Relugolix Pill
- +2 more
- (no location specified)
Dec 23, 2022
Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)
Active, not recruiting
- Advanced Cancer
- +16 more
-
Scottsdale, Arizona
- +3 more
Dec 22, 2022
Prostate Cancer Metastatic Trial in Ghent (radical prostatectomy, Whole pelvis radiotherapy)
Recruiting
- Prostate Cancer Metastatic
- radical prostatectomy
- Whole pelvis radiotherapy
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 16, 2022
Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev
Recruiting
- Prostate Cancer Metastatic
- +3 more
- Stereotactic body radiotherapy
- +3 more
-
Herlev, Capital Region, DenmarkDepartment of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022
Prostate Cancer, Prostate Cancer Metastatic, Metastatic Cancer Trial in Worldwide (radiation, procedure, drug)
Active, not recruiting
- Prostate Cancer
- +3 more
- whole pelvic radiotherapy
- +3 more
-
Melbourne, Australia
- +28 more
Dec 12, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer Trial in
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- +2 more
- 177Lu HTK03170
- 68Ga-HTK03149
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 28, 2022
Metastatic Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Trial in United States (Darolutamide, Enzalutamide)
Recruiting
- Metastatic Prostate Cancer
- +3 more
-
San Diego, California
- +11 more
Nov 28, 2022
Prostate Cancer Metastatic Trial in Peking (68Ga-PSMA-11, 68Ga-P15-041)
Recruiting
- Prostate Cancer Metastatic
-
Peking, ChinaPeking Union Medical College Hospital
Nov 25, 2022
Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)
Recruiting
- Prostate Cancer Metastatic
- Ablative Radiation Therapy
- Standard of care
-
Victoria, British Columbia, Canada
- +14 more
Nov 14, 2022
Prostate Cancer Metastatic, Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone)
Recruiting
- Prostate Cancer Metastatic
- Prostate Cancer
- Abiraterone Acetate
- Prednisone
-
Houston, Texas
- +2 more
Oct 7, 2022
Androgen Deprivation Therapy, Prostate Cancer, Prostate Cancer Metastatic Trial in Boston (Aerobic and resistance exercise,
Recruiting
- Androgen Deprivation Therapy
- +2 more
- Aerobic and resistance exercise
- Usual Care
-
Boston, MassachusettsDana Farber Cancer Institute
Oct 4, 2022
Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)
Not yet recruiting
- Prostate Cancer Metastatic
- Actinium-J591
- +2 more
-
New York, New YorkWeill Cornell Medicine - New York Presbyterian Hospital
Oct 3, 2022
Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)
Not yet recruiting
- Prostate Cancer Metastatic
- Pembrolizumab
- +2 more
- (no location specified)
Sep 29, 2022
Prostate Cancer Metastatic Trial in France (Darolutamide 300 mg, Placebo, Androgen deprivation therapy)
Recruiting
- Prostate Cancer Metastatic
- Darolutamide 300 mg
- +2 more
-
Avignon, France
- +44 more
Sep 28, 2022
Prostate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent Trial in Dallas (68Ga-PSMA-11, Positron Emission
Available
- Prostate Cancer
- +2 more
- 68Ga-PSMA-11
- Positron Emission Tomography/Computed Tomography
-
Dallas, TexasUT Southwestern Medical Center
Sep 27, 2022
Prostate-Specific Membrane Antigen PET Scans in People Prostate
Recruiting
- Prostate Cancer
- +4 more
- 18F-DCFPyL-iPSMA
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 29, 2022
Prostate Cancer Metastatic Trial in Worldwide (ARV-110 in Combination with Abiraterone)
Recruiting
- Prostate Cancer Metastatic
- ARV-110 in Combination with Abiraterone
-
Santa Monica, California
- +16 more
Jul 21, 2022